Fluctuations in disease activity scores for inflammatory joint disease in clinical practice: Do we need a solution?

Joint Bone Spine

Volumn 76, Issue 2, 2009, Pages 126-128

  Berthelot, Jean Marie ^a   Blanchais, Anne ^a   Marhadour, Thierry ^b   le Goff, Benoît ^a   Maugars, Yves ^a   Saraux, Alain ^b  

^a HÔTEL DIEU   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

ankylosing spondylitis; BASDAI; DAS 28; HAQ; patient reported outcome; RAPID; rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; RITUXIMAB;

ARTHRITIS; AS DAS SCORE; BASDAI SCORE; CLINICAL PRACTICE; DAS 28 SCORE; DISEASE ACTIVITY; EDITORIAL; HUMAN; MEASUREMENT; METROLOGY; SCORING SYSTEM; SELF EVALUATION;

ARTHRITIS, RHEUMATOID; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; JOINTS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 61649098127     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.12.002     Document Type: Editorial

References (20)

1. Cush J.J. Trends in rheumatology practice: a survey of US rheumatologists. Arthritis Rheum 58 9 Suppl (2008) S-747
2. Yazici Y., Bergman M., and Pincus T. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol 35 (2008) 603-609
3. Heikkilä S., Ronni S., Kautiainen H.J., and Kauppi M.J. Functional impairment in spondylarthropathy and fibromylagia. J Rheumatol 29 (2002) 1415-1419
4. Lukas C., Landewé R., Sieper J., et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 10.1136/ard.2008.094870
5. Wolfe F., Michaud K., Pincus T., Furst D., and Keystone E. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Arthritis Rheum 52 (2005) 3873-3879
6. Wolfe F., and Michaud K. Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices. Arthritis Rheum 56 (2007) 2135-2142
7. Marhadour T., Jousse-Joulin S., Chalès G., et al. Reliability meaning and consequences of the 'joint swelling item' estimation in the assessment of DAS 28 in rheumatoid arthritis (SEA-REPRO ancillary study). Ann Rheum Dis 67 (2008) 313
8. Berthelot J.M., Saulquin X., Coste-Burel M., et al. Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month follow-up pilot study. J Rheumatol 30 (2003) 1673-1679
9. Heiberg T., Kvien T.K., Dale O., et al. Daily health status registration (patient diary) in patients with rheumatoid arthritis: a comparison between personal digital assistant and paper-pencil format. Arthritis Rheum 57 (15 Apr 2007) 454-460
10. Berthelot J.M., Tortellier L., Lavy-Bregeon D., et al. High intraindividual week-to-week variability in BASDAI and BASFI values: are several evaluations needed before starting or stopping TNFalpha antagonist therapy for spondylarthropathies?. Joint Bone Spine 75 (2008) 167-171
11. Augustsson J., Jacobsson L.T., Nilsson J.A., et al. Patient-reported outcomes in RA treated with adalimumab using a personal digital assistant (PDA). Arthritis Rheum 58 9 Suppl (2008) a pilot project. S-750
12. Kvien T.K., Mowinckel P., Heiberg T., et al. Performance of health status measures with a pen based personal digital assistant. Ann Rheum Dis 64 (2005) 1480-1484
13. Welsing P.M., Landewé R.B., van Riel P.L., et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 50 (2004) 2082-2093
14. Mowinckel P., Hagen K.B., Heiberg T., and Kvien T.K. Repeated measures in rheumatoid arthritis reduced the required sample size in a two-armed clinical trial. J Clin Epidemiol 61 (2008) 940-944
15. Pincus T., Yazici Y., Bergman M., MacLean R., and Harrington T. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best Pract Res Clin Rheumatol 21 (2007) 789-804
16. Pincus T., Strand V., Koch G., et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 48 (2003) 625-630
17. Wolfe F., Michaud K., Gefeller O., et al. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 48 (2003) 1530-1542
18. Graudal N.A., Jurik A.G., de Carvalho A., et al. Radiographic progression in rheumatoid arthritis: a long-term prospective study of 109 patients. Arthritis Rheum 41 (1998) 1470-1480
19. Baralakios X., Listing J., von der Recke A., et al. The natural course of radiographic progression in ankylosing spondylitis. Evidence of non-linear progression in a large proportion of patients. Arthritis Rheum 58 9 Suppl (2008) S-357
20. Hewlett S., Kirwan J., Pollock J., et al. Patient initiated outpatient follow-up in rheumatoid arthritis: six year randomised controlled trial. BMJ 330 (2005) 171